Balance Sheet
Cash Flow Statement
Beginning Cash BalanceChange in Account PayablesCurrent DebtGains from Sales and DivestituresNet Debt Issuances and RepaymentsNon-cash ItemsOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Other Working Capital Changes: 2017-2025

Historic Other Working Capital Changes for China SXT Pharmaceuticals (SXTC) over the last 9 years, with Mar 2025 value amounting to $223,477.

  • China SXT Pharmaceuticals' Other Working Capital Changes rose 120.95% to $65,057 in Q3 2025 from the same period last year, while for Sep 2025 it was $887, marking a year-over-year increase of 100.03%. This contributed to the annual value of $223,477 for FY2025, which is 256.09% up from last year.
  • According to the latest figures from FY2025, China SXT Pharmaceuticals' Other Working Capital Changes is $223,477, which was up 256.09% from -$143,175 recorded in FY2024.
  • Over the past 5 years, China SXT Pharmaceuticals' Other Working Capital Changes peaked at $1.0 million during FY2021, and registered a low of -$1.0 million during FY2022.
  • Moreover, its 3-year median value for Other Working Capital Changes was $94,339 (2023), whereas its average is $58,214.
  • As far as peak fluctuations go, China SXT Pharmaceuticals' Other Working Capital Changes plummeted by 251.77% in 2024, and later surged by 256.09% in 2025.
  • MRY analysis of 5 years shows China SXT Pharmaceuticals' Other Working Capital Changes stood at $1.0 million in 2021, then crashed by 198.54% to -$1.0 million in 2022, then skyrocketed by 109.21% to $94,339 in 2023, then plummeted by 251.77% to -$143,175 in 2024, then surged by 256.09% to $223,477 in 2025.
  • Its Other Working Capital Changes was $223,477 in FY2025, compared to -$143,175 in FY2024 and $94,339 in FY2023.